pharma · Psoriasis · EGFR Positive Non-small Cell Lung Cancer
Betta Pharmaceuticals Co
Betta Pharmaceuticals Co.,
Betta Pharmaceuticals Co is a pharma organization headquartered in CN. Primary therapeutic focus areas include Psoriasis, EGFR Positive Non-small Cell Lung Cancer. NovaPharmaNews links 2 clinical program(s), 0 drug profi
Hangzhou, CN HQ
23 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Hangzhou, CN
- Employees
- 23
- Programs
- 2
- Drugs
- 4
- Patents
- 0
Sequential Icotinib Plus Chemotherapy
Approved · small molecule · EGFR Positive Non-small Cell Lung Cancer
Sequential Icotinib Plus Chemotherapy for EGFR Positive Non-small Cell Lung Cancer is a Approved program (small_molecule) at Betta Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).
Internal code BD-IC-IV62
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Betta Pharmaceuticals Co.,
- Phase
- Approved
- Modality
- small_molecule
- Indication
- EGFR Positive Non-small Cell Lung Cancer
- Status
- active
- Trials
- 1